Kazimierz Ciechanowski

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Novel Once-Daily Extended-Release Tacrolimus (LCPT) Versus Twice-Daily Tacrolimus in De Novo Kidney Transplants: One-Year Results of Phase III, Double-Blind, Randomized Trial

Klemens Budde, Suphamai Bunnapradist, Josep M. Grinyó et al. · American Journal of Transplantation · 2014 · 121 citations · Full text

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 118 citations · Full text

Everolimus plus early tacrolimus minimization: a phase III, randomized, open-label, multicentre trial in renal transplantation

R.M. Langer, Ronald J. Hené, Maarten H. L. Christiaans et al. · Transplant International · 2012 · 116 citations

Sarcopenia: A Major Challenge in Elderly Patients with End-Stage Renal Disease

Maciej Domański, Kazimierz Ciechanowski · Journal of Aging Research · 2012 · 100 citations · Full text

Aging, Elderly Patients, Renal Pathology +20